878110P
C16-02:0 PC
Manufacturer: Sigma Aldrich
CAS Number: 74389-68-7
Synonym(S): 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 5 MG | 878110P-5-MG | In Stock | ₹ 18,510.75 |
| 25 MG | 878110P-25-MG | In Stock | ₹ 65,177.33 |
878110P - 5 MG
In Stock
Quantity
1
Base Price: ₹ 18,510.75
GST (18%): ₹ 3,331.935
Total Price: ₹ 21,842.685
form
powder
packaging
pkg of 1 × 25 mg (878110P-25mg)pkg of 1 × 5 mg (878110P-5mg)
manufacturer/tradename
Avanti Polar Lipids 878110P
lipid type
phosphoglyceridesbioactive lipids
shipped in
dry ice
storage temp.
−20°C
SMILES string
[O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(C)=O)COCCCCCCCCCCCCCCCC)=O
InChI
1S/C26H54NO7P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-31-23-26(34-25(2)28)24-33-35(29,30)32-22-20-27(3,4)5/h26H,6-24H2,1-5H3/t26-/m1/s1
InChI key
HVAUUPRFYPCOCA-AREMUKBSSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Enzo Life Sciences 1-O-Hexadecyl-2-O-acetyl-sn-glycero-3-phosphorylcholine (5mg). CAS: 74389-68-7 | -- | ₹ 8,265.10 | |
| | C16-02:0 PC | -- | ₹ 48,964.05 | |
| | 74389-68-7 | Paf (c16) | -- | ₹ 2,823.48 - ₹ 19,849.92 |
Related Products
Description
- General description: C16-02:0 PC, also referred as 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (C16 PAF) (acetyl PAF), is a platelet-activating factor (PAF). Acetyl PAF is a natural PAF with ether-linked hexadecyl chain at the sn-1 position and an acetyl group at the sn-2 position.[1]
- Application: C16-02:0 PC or 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine may be used as a substrate in enzymatic lipoprotein-associated phospholipase A2 (Lp-PLA2) activity assay.[2] It may also be used to study its physicochemical properties and its interaction with peptides derived from the C-terminal domains of human apolipoprotein E.[1]
- Biochem/physiol Actions: C16-02:0 PC, a platelet-activating factor and a lipid mediator is involved in various inflammatory diseases.[3] It facilitates initiation and progression of atherosclerosis. PAF acts as a potential biomarker for coronary artery diseases. It exhibits its activity by binding to a specific PAF receptor, which belongs to the seven transmembrane-spanning G-protein-linked receptors family. PAF on hydrolysis by platelet-activating factor-acetyl hydrolase produces LysoPAF (1-O-alkyl-2-hydroxy-sn-glycero-3-phosphocholine).[2]
- Packaging: 5 mL Clear Glass Sealed Ampule (878110P-25mg)
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable